HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes (Q46757223)

24 December 2017

title

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes (English)

1 reference

24 December 2017

9

Ascher NL

1 reference

24 December 2017

John P. Roberts

10

object named as

Roberts JP

1 reference

24 December 2017

Norah A Terrault

5

object named as

Terrault NA

1 reference

24 December 2017

author name string

Roland ME

1

1 reference

24 December 2017

Barin B

2

1 reference

24 December 2017

Carlson L

3

1 reference

24 December 2017

Frassetto LA

4

1 reference

24 December 2017

Hirose R

6

1 reference

24 December 2017

Freise CE

7

1 reference

24 December 2017

Benet LZ

8

1 reference

24 December 2017

Murphy B

11

1 reference

24 December 2017

Keller MJ

12

1 reference

24 December 2017

Olthoff KM

13

1 reference

24 December 2017

Blumberg EA

14

1 reference

24 December 2017

Brayman KL

15

1 reference

24 December 2017

Bartlett ST

16

1 reference

24 December 2017

Davis CE

17

1 reference

24 December 2017

McCune JM

18

1 reference

24 December 2017

Bredt BM

19

1 reference

24 December 2017

Stablein DM

20

1 reference

24 December 2017

Stock PG

21

1 reference

24 December 2017

language of work or name

English

0 references

publication date

18 December 2007

1 reference

24 December 2017

American Journal of Transplantation

published in

1 reference

24 December 2017

volume

8

1 reference

24 December 2017

page(s)

355-365

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

Determinants of survival among HIV-infected chronic dialysis patients

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Solid-organ transplantation in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Transplantation in HIV+ patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Review of solid-organ transplantation in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Pharmacokinetic interactions between cyclosporine and protease inhibitors in HIV+ subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02061.X

10.1111/J.1600-6143.2007.02061.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18093266

1 reference

24 December 2017